Central Institute for Experimental Animals, 1430 Nogawa, Miyamae, Kawasaki, Kanagawa 216-0001, Japan.
Res Vet Sci. 2012 Oct;93(2):624-6. doi: 10.1016/j.rvsc.2011.11.001. Epub 2011 Nov 29.
To reveal the current status of the prevalence of Bordetella hinzii in mice in experimental facilities in Japan, a survey of this agent was performed by culture of tracheal swabs from a total of 12,923 mice from 1699 facilities (12,192 mice from 1572 facilities in universities and research institutes and 731 mice from 127 facilities in pharmaceutical companies) in total. In the results, 195 out of 12,192 mice (1.6%) from 44 out of 1572 facilities (2.8%) in universities and research institutes were positive for B. hinzii. No B. hinzii-positive mice were found in 127 pharmaceutical companies surveyed. Gross lesions in the lungs with isolation of B. hinzii were observed in seven mice from four universities, and the lesions were identified as bronchopneumonia histopathologically. To our knowledge, this is the first report to reveal the prevalence of B. hinzii in laboratory mice.
为了揭示日本实验设施中支气管败血波氏杆菌(Bordetella hinzii)在小鼠中的流行现状,对来自 1699 个设施的 12923 只小鼠的气管拭子进行了培养,其中包括 1572 个来自大学和研究所的 12192 只小鼠和 127 个来自制药公司的 731 只小鼠。结果,在 44 个来自大学和研究所的 1572 个设施(2.8%)中的 12192 只小鼠中,有 195 只(1.6%)为支气管败血波氏杆菌阳性。在调查的 127 家制药公司中未发现阳性小鼠。从四所大学的七只小鼠中分离出支气管败血波氏杆菌,并观察到肺部肉眼可见病变,组织病理学鉴定为支气管肺炎。据我们所知,这是首次报道实验室小鼠中支气管败血波氏杆菌的流行情况。